Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A lands $12.2mm for Molecular Assemblies

Executive Summary

Molecular Assemblies Inc. (DNA synthesis technology) raised $12.2mm in its Series A financing led by iSelect Fund, which was joined by returning shareholders Agilent Technologies, Alexandria Venture Investments, and Keshif Ventures. The company will use the funds to advance its enzymatic DNA synthesis technology to power DNA-based products in synthetic biology. Its approach aims to produce long, high-quality, sequence-specific DNA in a reliable, affordable and sustainable process.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
    • Nanotechnology, Chips, etc.
    • Synthesis Technologies, Production Processes
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies